Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael

Showing results (71-80 of 1,129) with videos related to

Pageof 113
Sort By:
Reviews in Endocrine & Metabolic Disorders|February 10, 2010
Monitoring pharmacological therapy for osteoporosisE Michael Lewiecki
Journal of Women'S Health (2002)|October 28, 2009
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|November 24, 2005
Update on bone density testingE Michael Lewiecki
Southern Medical Journal|December 17, 2008
Phytoestrogens and their role in the management of postmenopausal osteoporosisE Michael Lewiecki
Southern Medical Journal|May 23, 2006
Augmentation procedures for osteoporotic vertebral fractures--an ongoing experiment or emerging standard of care?E Michael Lewiecki
Developmental Psychology|August 4, 2010
Causal inference and developmental psychologyE Michael Foster
Current Rheumatology Reports|July 17, 2009
Denosumab for joints and bonesE Michael Lewiecki
Nature Clinical Practice. Rheumatology|December 19, 2008
Is denosumab better than alendronate in the treatment of osteoporosis?E Michael Lewiecki
Current Medical Research and Opinion|September 18, 2007
Long dosing intervals in the treatment of postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Emerging Drugs|March 3, 2009
Emerging drugs for postmenopausal osteoporosisE Michael Lewiecki
Pageof 113

Showing results (71-80 of 1,129) with videos related to

Sort By:
Pageof 113
Reviews in Endocrine & Metabolic Disorders|February 10, 2010
Monitoring pharmacological therapy for osteoporosisE Michael Lewiecki
Journal of Women'S Health (2002)|October 28, 2009
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|November 24, 2005
Update on bone density testingE Michael Lewiecki
Southern Medical Journal|December 17, 2008
Phytoestrogens and their role in the management of postmenopausal osteoporosisE Michael Lewiecki
Southern Medical Journal|May 23, 2006
Augmentation procedures for osteoporotic vertebral fractures--an ongoing experiment or emerging standard of care?E Michael Lewiecki
Developmental Psychology|August 4, 2010
Causal inference and developmental psychologyE Michael Foster
Current Rheumatology Reports|July 17, 2009
Denosumab for joints and bonesE Michael Lewiecki
Nature Clinical Practice. Rheumatology|December 19, 2008
Is denosumab better than alendronate in the treatment of osteoporosis?E Michael Lewiecki
Current Medical Research and Opinion|September 18, 2007
Long dosing intervals in the treatment of postmenopausal osteoporosisE Michael Lewiecki
Expert Opinion on Emerging Drugs|March 3, 2009
Emerging drugs for postmenopausal osteoporosisE Michael Lewiecki
Pageof 113